EP2 receptor antagonist-3 is a selectiveEP2 receptorantagonist (IC50: 8 nM in hEP2 SPA assay, 50 nM in hEP2 cAMP assay). EP2 receptor antagonist-3 increases the macrophage-mediated clearance ofAmyloid-βplaques. EP2 receptor antagonist-3 can be used for the study of alzheimer’s diseases[1].
References:
[1].Fox BM, et al. A selective prostaglandin E2 receptor subtype 2 (EP2) antagonist increases the macrophage-mediated clearance of amyloid-beta plaques. J Med Chem. 2015 Jul 9;58(13):5256-73.
















